Journal scan

Drug treatment has little effect on hip fracture risk and may be a waste of money

The current focus on drug treatments to prevent hip fractures is neither viable as a public health strategy nor cost effective, suggests an analysis of the evidence by an international team of researchers.

This article is for subscribers only